The anti-phospholipid antibody syndrome: Clinical and serological aspects

Bailliere's Best Practice and Research in Clinical Rheumatology

Volumn 14, Issue 1, 2000, Pages 139-150

  Alarcón Segovia, Donato ^a,b   Cabral, Antonio R ^a,b  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Anti cardiolipin antibodies; Anti phospholipid syndrome; Anti 2 glycoprotein I; Autoantibodies; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; PHOSPHOLIPID; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; CLINICAL FEATURE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; REVIEW; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0343673865     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1053/berh.1999.0082     Document Type: Article

References (54)

1. Bowie W EJ, Thompson J H, Pascuzzi C A, Owen G A. Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. Journal of Clinical Investigation. 62:1963;416-430.
2. Alarcón-Segovia D, Osmundson P J. Peripheral vascular syndromes associated with systemic lupus erythematosus. Annals of Internal Medicine. 62:1965;907-919.
3. Nilsson I M, Astedt B, Heder H, Berezin D. Intrauterine death and circulating anticoagulant ('antithromboplastin'). Acta Medica Scandinavica. 197:1975;153-159.
4. Soulier J P, Boffa M C. Avortements à répétition, thromboses et anticoagulant circulant anti-thromboplastine. Nouvelle Press Médicale. 9:1980;859-864.
5. Loizou S, McCrea J D, Rudge A C. Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA). Standardization and quantitation of results. Clinical and Experimental Immunology. 62:1985;738-745.
6. Hughes G RV, Harris E N, Gharavi A E. The anticardiolipin syndrome. Journal of Rheumatology. 13:1986;486-489.
7. Harris E N, Gharavi A E, Boey M L. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet. ii:1983;1211-1214.
8. Harris E N, Chan J KH, Asherson R A. Thrombosis, recurrent fetal loss and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Archives of Internal Medicine. 146:1986;2153-2156.
9. Koike T, Sueishi M, Funkai H, Tomioka H, Yoshida S. Anti-phospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus. Clinical and Experimental Immunology. 56:1984;193-199.
10. Lockshin M D, Druzin M L, Goei S. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. New England Journal of Medicine. 313:1985;152-156.
11. Alarcón-Segovia D, Delezé M, Oria C V. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine. 68:1989;353-365.
12. Lavalle C, Pizarro S, Drenkard C, Sánchez-Guerrero J, Alarcón-Segovia D. Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies. Journal of Rheumatology. 17:1990;34-37.
13. Drenkard C, Villa A R, Reyes E, Abello M, Alarcón-Segovia D. Vasculitis in systemic lupus erythematosus. Lupus. 6:1997;235-242.
14. Asherson R A, Lioté F, Pages B. Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. Journal of Rheumatology. 20:1993;284-288.
15. Herranz M T, Rivier G, Khamashta M A, Blaser K U, Hughes G RV. Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Arthritis and Rheumatism. 37:1994;568-571.
16. Alarcón-Segovia D, Estañol B, García-Ramos G, Villa A R. Antiphospholipid antibodies in the antiphospholipid syndrome. Clinical relevance in neuropsychiatric systemic lupus erythematosus. Annals of the New York Academy of Sciences. 823:1997;279-288.
17. Tenneti L, D'Emilia D M, Troy C M, Lipton S A. Role of caspases in N -methyl- D -aspartate-induced apoptosis in cerebrocortical neurons. Journal of Neurochemistry. 71:1998;946-959.
18. Alarcón-Segovia D, Sánchez-Guerrero J. Primary antiphospholipid syndrome. Journal of Rheumatology. 16:1989;482-489.
19. Mackworth-Young C G, Loizou S, Walport M J. Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder. Annals of Rheumatic Diseases. 48:1989;362-367.
20. Asherson R A, Khamashta M A, Ordi-Ros J. The 'primary' antiphospholipid syndrome: major clinical and serological features. Medicine. 68:1989;366-374.
21. Vianna J L, Khamashta M A, Ordi-Ros J. Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter study of 114 patients. American Journal of Medicine. 96:1994;3-9.
22. Cardiel H. Síndrome de antifosfolípido primario (SAFP). Informe inicial de 51 pacientes. Grupo Multicéntrico de la Ciudad de México. Revista Mexicana de Reumatología. 7:1992;4.
23. Alarcón-Segovia D, Cabral A R. Antiphospholipid/cofactor syndromes. Rose N R, Mackay I R. The Autoimmune Diseases. 1998;299-316 Academic Press, San Diego.
24. Cabral A R, Alarcón-Segovia D. Will some day PAPS fade into SLE? Lupus. 5:1996;4-5.
25. Galli M, Finazzi G, Barbui T. Antiphospholipid antibodies: predictive value of laboratory tests. Thrombosis and Haemostasis. 78:1997;75-78.
26. Galli M, Finazzi G, Norbis F, Marchioli R, Barbui T. The risk of thrombosis in patients with lupus anticoagulants is predicted by their specific coagulation profile. Thrombosis and Haemostasis. 81:1999;695-700.
27. Smolarsky M. A simple radiommunoassay to determine binding of antibodies to lipid antigens. Journal of Immunological Methods. 38:1980;85-93.
28. Alarcón-Segovia D, Pérez-Vázquez M E, Villa A R, Drenkard C, Cabiedes J. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Seminars in Arthritis and Rheumatism. 21:1992;275-286.
29. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa T, Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet. 336:1990;177-178.
30. 2-glycoprotein I (apolipoprotein H). Proceedings of the National Academy of Sciences of the USA. 87:1990;4120-4124.
31. Galli M, Comfurius P, Maassen C. Anticardiolipin antibodies (ACA) are directed not to cardiolipin but to a plasma protein cofactor. Lancet. 335:1990;1544-1547.
32. Cabral A R, Alarcón-Segovia D. Bromelain-treated erythrocyte autoantibodies. Peter J B, Shoenfeld Y. Autoantibodies. 1996;120-125 Elsevier, Amsterdam.
33. Cabral A R, Cabiedes J, Alarcón-Segovia D. Hemolytic anemia related to an IgM autoantibody to phosphatidylcholine that binds in vitro to stored and to bromelain-treated erythrocytes. Journal of Autoimmunity. 3:1990;773-787.
34. Berard M, Chantome R, Marcelli A, Boffa M C. Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies. I. Association with thrombosis and vascular cutaneous disease. Journal of Rheumatology. 23:1996;1369-1374.
35. Vaarala O, Alfthan G, Jauhiainen M. Crossreaction between antibodies to oxidised low-density lipoprotein and cardiolipin in systemic lupus erythematosus. Lancet. 341:1993;923-925.
36. Horkko S, Miller E, Dudi E. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. Journal of Clinical Investigation. 98:1996;815-825.
37. Amengual O, Atsumi T, Khamashta M A, Tinahones F, Hughes G RV. Autoantibodies against oxidized low-density lipoprotein in antiphospholipid syndrome. British Journal of Rheumatology. 36:1997;964-968.
38. 2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein. British Journal of Rheumatology. 37:1998;883-888.
39. 2-glycoprotein I immunoassays in the diagnosis of antiphospholipid syndrome. Clinical and Experimental Rheumatology. 16:1998;396-402.
40. 2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding. Journal of Immunology. 154:1995;954-960.
41. 2-glycoprotein-I in the serum of patients with primary antiphospholipid syndrome. Journal of Rheumatology. 22:1995;1894-1898.
42. 2-glycoprotein-I than with antiphospholipid antibodies. Journal of Rheumatology. 22:1995;1899-1906.
43. 2-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays. American Journal of Medicine. 101:1996;472-481.
44. 2-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays. Journal of Rheumatology. 24:1997;1545-1551.
45. 2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients. American Journal of Medicine. 106:1999;417-423.
46. Fleck R A, Rapaport S I, Mohan-Rao V. Anti-prothrombin antibodies and the lupus anticoagulant. Blood. 72:1988;512-519.
47. Arvieux J, Darnige L, Caron C. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thrombosis and Haemostasis. 74:1995;1120-1125.
48. Galli M, Barbui T. Antiprothrombin antibodies: detection and clinical significance in the antiphospholipid syndrome. Blood. 93:1999;2149-2157.
49. Alarcón-Segovia D, Cabral A R. Antiphospholipid/cofactor syndromes. Journal of Rheumatology. 23:1996;1319-1322.
50. George J, Gilburd B, Levy Y. Atherosclerosis in LDL-receptor knockout mice is accelerated by immunization with anticardiolipin antibodies. Lupus. 6:1997;723-729.
51. 2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression. Circulation. 99:1999;2227-2230.
52. Pérez Vazquez M E, Cabiedes J, Cabral A R, Alarcón-Segovia D. Decrease in serum antiphospholipid antibody levels upon development of nephrotic syndrome in patients with systemic lupus erythematosus: relationship to urinary loss of IgG and other factors. American Journal of Medicine. 92:1992;357-362.
53. 2GP-I) in hypertensive disorders of pregnancy. Lupus. 7:1998;113.
54. Wilson W A, Gharavi A E, Koike T. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Report of an International Workshop. Arthritis and Rheumatism. 42:1999;1309-1311.